Corcept Therapeutics (CORT) Other Non-Current Assets (2010 - 2026)

Corcept Therapeutics has disclosed Other Non-Current Assets across 17 years of filings, most recently posting $5.2 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $5.2 million, down 22.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (down 22.04% YoY), and the FY2025 annual result was $5.2 million, down 22.04% from the prior year.
• Other Non-Current Assets came in at $5.2 million for Q1 2026 at Corcept Therapeutics, roughly flat from $5.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $8.3 million in Q2 2025 to a low of $1.8 million in Q2 2022.
• The 5-year median for Other Non-Current Assets is $6.4 million (2024), against an average of $5.7 million.
• Across the five-year window, Other Non-Current Assets plunged 55.7% in 2022 and surged 140.62% in 2023, its largest moves.
• Corcept Therapeutics' Other Non-Current Assets stood at $5.1 million in 2022, then increased by 29.32% to $6.5 million in 2023, then rose by 1.05% to $6.6 million in 2024, then decreased by 22.04% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $5.2 million (Q1 2026), $5.2 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.